Preoperative use of mupirocin for the prevention of healthcare-associated Staphylococcus aureus infections: a cost-effectiveness analysis.

Young, Lisa S; Winston, Lisa G

Young, Lisa S; Winston, Lisa G.

Affiliation

Young LS; Department of Medicine, University of California, San Francisco, CA, USA. Lisa.Young@UCHSC.edu

Infect Control Hosp Epidemiol ; 27(12): 1304-12, 2006 Dec.

Article in En | MEDLINE | ID: mdl-17152027

Subject(s)

Anti-Bacterial Agents/economics; Cost-Benefit Analysis; Mupirocin/therapeutic use; Staphylococcal Infections/prevention & control; Surgical Wound Infection/prevention & control; Anti-Bacterial Agents/administration & dosage; Anti-Bacterial Agents/therapeutic use; Cost Savings; Cross Infection/prevention & control; Decision Trees; Mupirocin/administration & dosage; Mupirocin/economics; Nose/microbiology; Sensitivity and Specificity; Staphylococcal Infections/economics; Staphylococcus aureus/isolation & purification

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcal Infections / Surgical Wound Infection / Mupirocin / Cost-Benefit Analysis / Anti-Bacterial Agents Type of study: Diagnostic_studies / Evaluation_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Language: En Journal: Infect Control Hosp Epidemiol Journal subject: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Year: 2006 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links